Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial)
Mathiasen, Anders Bruun, MD, Jørgensen, Erik, MD, Qayyum, Abbas Ali, MD, Haack-Sørensen, Mandana, MSc, PhD, Ekblond, Annette, MSc, PhD, Kastrup, Jens, MD, DMSc
Published in The American heart journal (01.09.2012)
Published in The American heart journal (01.09.2012)
Get full text
Journal Article